Abstract
We aim to assess visual acuity (VA) in Congenital Zika Syndrome (CZS)-children to evaluate visual loss. To that end we evaluated 41 CZS- children, from Rio de Janeiro using Teller Acuity Cards. They had Zika virus-infection confirmed by reverse transcription–polymerase chain reaction (RT-PCR) or clinical evaluation. VA below normative values was present in 39/41 (95%). In 10 cases, VA was only marginally below normal; in the remaining 29 cases, VA was more than 0.15 logMAR below the lower limit. There was no relationship between VA and cognitive domain tasks, although there was a relationship between VA and motor domain tasks. Thirty-seven children performed at least one task in the cognitive set, 14 children did not perform any task in the motor set. Children with VA above the lower limit performed better in the cognitive and motor tasks. We concluded that ZIKV- infected children with CSZ were highly VA impaired which correlated with motor performance, but not with cognitive performance. Part of the children had VA within the normal limits and displayed better performance in the cognitive and motor set. Therefore, even if heavily impaired, most children had some degree of visual acuity and visual function and may benefit from visual rehabilitation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by Sao Paulo State Research Foundation (FAPESP) Thematic Project #2014/268182 and Coordination for the Improvement of Higher Level Education Personnel (CAPES) Pro Amazonia 2013/3263 grant to DFV. RDH was received by DFV as Visiting Professor through a Science Without Borders CAPES grant. Authors LB (#2016/147930), DSL (#2016/246318), LAS (#2017/169484), HST (#2016/21573-7) had MSc student fellowships from FAPESP, while KSV and VCRMF had FAPESP postdoctoral fellowships. Author DD had a CAPES doctoral fellowship. DFV and MFC are National Council for Scientific and Technological Development (CNPq) Productivity Research Fellows. The sponsors or funding organizations had no role in the design or conduct of this research. CNPq 441098/2016-9 and 305090/2016-0; Faperj E_18/2015TXB; Welcome Trust & the United Kingdom Department for International Development (205377/Z/16/Z); European Union Horizon 2020 research and innovation programme under Zika PLAN grant agreement no. 734584.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research was approved by the Ethics Committee for Human Research of the University of Sao Paulo Institute of Psychology (number 67031216.0.0000.5561) and by the Ethics Committee for Human Research of the Institute Fernandes Figueira (IFF) Fiocruz (number 526756616000005269).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
